Published in Magn Reson Med on September 01, 2000
Effect of hypoglycemia on brain glycogen metabolism in vivo. J Neurosci Res (2003) 1.64
Localized in vivo 13C NMR spectroscopy of the brain. NMR Biomed (2003) 1.55
State of the art direct 13C and indirect 1H-[13C] NMR spectroscopy in vivo. A practical guide. NMR Biomed (2011) 1.19
In vivo 13C magnetic resonance spectroscopy of human brain on a clinical 3 T scanner using [2-13C]glucose infusion and low-power stochastic decoupling. Magn Reson Med (2009) 1.14
Dynamic or inert metabolism? Turnover of N-acetyl aspartate and glutathione from D-[1-13C]glucose in the rat brain in vivo. J Neurochem (2004) 1.08
Biochemical quantification of total brain glycogen concentration in rats under different glycemic states. Neurochem Int (2006) 1.03
Effect of chronic hypoglycaemia on glucose concentration and glycogen content in rat brain: A localized 13C NMR study. J Neurochem (2006) 1.00
Glutamate and glutamine: a review of in vivo MRS in the human brain. NMR Biomed (2013) 0.90
Non-invasive quantification of brain glycogen absolute concentration. J Neurochem (2008) 0.87
Relaxivity of Gd-based contrast agents on X nuclei with long intrinsic relaxation times in aqueous solutions. Magn Reson Imaging (2007) 0.85
Direct validation of in vivo localized 13C MRS measurements of brain glycogen. Magn Reson Med (2007) 0.83
Cerebral glutamine metabolism under hyperammonemia determined in vivo by localized (1)H and (15)N NMR spectroscopy. J Cereb Blood Flow Metab (2011) 0.82
Silencing of the glycerophosphocholine phosphodiesterase GDPD5 alters the phospholipid metabolite profile in a breast cancer model in vivo as monitored by (31) P MRS. NMR Biomed (2014) 0.77
1H/31P polarization transfer at 9.4 Tesla for improved specificity of detecting phosphomonoesters and phosphodiesters in breast tumor models. PLoS One (2014) 0.76
Combination of two fat saturation pulses improves detectability of glucose signals in carbon-13 MR spectroscopy. Proc Jpn Acad Ser B Phys Biol Sci (2011) 0.75
In vivo N-15 MRS study of glutamate metabolism in the rat brain. Anal Biochem (2016) 0.75
Simultaneous in vivo spectral editing and water suppression. NMR Biomed (1998) 5.09
In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time. Magn Reson Med (1999) 4.26
Field mapping without reference scan using asymmetric echo-planar techniques. Magn Reson Med (2000) 3.13
Toward an in vivo neurochemical profile: quantification of 18 metabolites in short-echo-time (1)H NMR spectra of the rat brain. J Magn Reson (1999) 2.42
In vivo 1H NMR spectroscopy of the human brain at 7 T. Magn Reson Med (2001) 2.12
Simultaneous determination of the rates of the TCA cycle, glucose utilization, alpha-ketoglutarate/glutamate exchange, and glutamine synthesis in human brain by NMR. J Cereb Blood Flow Metab (1995) 1.98
A half-volume coil for efficient proton decoupling in humans at 4 tesla. J Magn Reson (1997) 1.84
Assessment of adrenoleukodystrophy lesions by high field MRS in non-sedated pediatric patients. Neurology (2005) 1.73
Echo-planar magnetic resonance imaging studies of frontal cortex activation during word generation in humans. Proc Natl Acad Sci U S A (1993) 1.60
In vivo measurements of brain glucose transport using the reversible Michaelis-Menten model and simultaneous measurements of cerebral blood flow changes during hypoglycemia. J Cereb Blood Flow Metab (2001) 1.52
The effect of insulin on in vivo cerebral glucose concentrations and rates of glucose transport/metabolism in humans. Diabetes (2001) 1.40
[Relationship of the CDKAL1 and KCNQ1 gene polymorphisms to the age at diagnosis of type 2 diabetes in the Slovakian population]. Vnitr Lek (2011) 1.39
Methodology of H NMR Spectroscopy of the Human Brain at Very High Magnetic Fields. Appl Magn Reson (2005) 1.25
Temporal and spatial analysis of fields generated by eddy currents in superconducting magnets: optimization of corrections and quantitative characterization of magnet/gradient systems. Magn Reson Med (1991) 1.19
Extracellular-intracellular distribution of glucose and lactate in the rat brain assessed noninvasively by diffusion-weighted 1H nuclear magnetic resonance spectroscopy in vivo. J Cereb Blood Flow Metab (2000) 1.18
Absolute metabolite quantification by in vivo NMR spectroscopy: II. A multicentre trial of protocols for in vivo localised proton studies of human brain. Magn Reson Imaging (1998) 1.18
Noninvasive measurements of [1-(13)C]glycogen concentrations and metabolism in rat brain in vivo. J Neurochem (1999) 1.14
Water diffusion in rat brain in vivo as detected at very large b values is multicompartmental. MAGMA (1999) 1.12
Magnetic resonance studies of brain function and neurochemistry. Annu Rev Biomed Eng (2000) 1.11
Study of tricarboxylic acid cycle flux changes in human visual cortex during hemifield visual stimulation using (1)H-[(13)C] MRS and fMRI. Magn Reson Med (2001) 1.08
Localized in vivo 1H NMR detection of neurotransmitter labeling in rat brain during infusion of [1-13C] D-glucose. Magn Reson Med (1999) 1.02
Lactate turnover in rat glioma measured by in vivo nuclear magnetic resonance spectroscopy. Cancer Res (1998) 0.99
Temporal SNR characteristics in segmented 3D-EPI at 7T. Magn Reson Med (2011) 0.97
Hyperpolarizing gases via dynamic nuclear polarization and sublimation. Phys Rev Lett (2010) 0.97
In vivo magnetic resonance spectroscopy of human brain: the biophysical basis of dementia. Biophys Chem (1997) 0.95
Localized eddy current compensation using quantitative field mapping. J Magn Reson (1998) 0.94
Metabolic changes in quinolinic acid-lesioned rat striatum detected non-invasively by in vivo (1)H NMR spectroscopy. J Neurosci Res (2001) 0.94
Identification of a high concentration of scyllo-inositol in the brain of a healthy human subject using 1H- and 13C-NMR. Magn Reson Med (1998) 0.87
Diffusion-weighted spectroscopy: a novel approach to determine macromolecule resonances in short-echo time 1H-MRS. Magn Reson Med (2010) 0.85
Effect of gene polymorphisms on lipoprotein levels in patients with dyslipidemia of metabolic syndrome. Physiol Res (2005) 0.83
Whole-brain glutamate metabolism evaluated by steady-state kinetics using a double-isotope procedure: effects of gabapentin. J Neurochem (2004) 0.83
Metabolic changes in rat brain after prolonged ethanol consumption measured by 1H and 31P MRS experiments. Cell Mol Neurobiol (2000) 0.81
In vivo observation of lactate methyl proton magnetization transfer in rat C6 glioma. Magn Reson Med (1999) 0.81
Detecting natural abundance carbon signal of NAA metabolite within 12-cm3 localized volume of human brain using 1H-[13C] NMR spectroscopy. Magn Reson Med (1998) 0.81
Brain lactate by magnetic resonance spectroscopy during fulminant hepatic failure in the dog. Liver Transpl Surg (1998) 0.80
Carotid intima-media thickness in relation to macrovascular disease in patients with type 2 diabetes mellitus. Wien Klin Wochenschr (2000) 0.80
Motion artifacts reduction in DWI using navigator echoes: a robust and simple correction scheme. MAGMA (1998) 0.78
Relationship among urinary albumin excretion rate, lipoprotein lipase PvuII polymorphism and plasma fibrinogen in type 2 diabetic patients. Physiol Res (2005) 0.78
Important contribution of lipoprotein particle number to plasma triglyceride concentration in type 2 diabetes. Atherosclerosis (1998) 0.77
An in vivo ultrahigh field 14.1 T (1) H-MRS study on 6-OHDA and α-synuclein-based rat models of Parkinson's disease: GABA as an early disease marker. NMR Biomed (2012) 0.77
Absolute metabolite quantification by in vivo NMR spectroscopy: III. Multicentre 1H MRS of the human brain addressed by one and the same data-analysis protocol. Magn Reson Imaging (1998) 0.77
Synchronization device for electrocardiography-gated echo-planar imaging. Radiology (1995) 0.76
Variations in the in vivo P-31 MR spectra of the developing human brain during postnatal life. Work in progress. Radiology (1989) 0.76
[Hypercoagulation states]. Vnitr Lek (1993) 0.76
Type IV renal tubular acidosis associated with Alport's syndrome. Postgrad Med J (1993) 0.75
Spirometric alterations in patients with reduced renal function. Wien Klin Wochenschr (1993) 0.75
Cardiovascular risk factors as predictors of mortality in type II diabetic patients. Wien Klin Wochenschr (1999) 0.75
[Echocardiographic findings in patients on a long-term dialysis regimen]. Vnitr Lek (1988) 0.75
[ECG Holter monitoring in patients with chronic renal failure in a long-term dialysis program]. Vnitr Lek (1992) 0.75
[Rapid control of acute hypertensive conditions by administration of sublingual nifedipine]. Vnitr Lek (1986) 0.75
[The present status of treatment of unstable angina pectoris]. Vnitr Lek (1994) 0.75
[Effect of bisoprolol on heart rate variability in patients with hyperthyroidism]. Vnitr Lek (2000) 0.75
Application of NMR spectroscopy in biochemical studies of tumor cells sensitive and resistant to anticancer drugs. Neoplasma (1998) 0.75
New approach for quantitation of short echo time in vivo 1H MR spectra of brain using AMARES. NMR Biomed (1998) 0.75
[Relation of polymorphism of genes controlling endothelial function and blood pressure and the occurrence of vascular complications in type 2 diabetes]. Vnitr Lek (2002) 0.75
[Evans' syndrome]. Vnitr Lek (1988) 0.75
[Infections of the diabetic foot--etiopathogenesis and possible preventive strategies]. Vnitr Lek (1998) 0.75
[Pulmonary embolism as a rare complication of a contusion in the inguinal region]. Vnitr Lek (1992) 0.75
[Neurohumoral activity in liver cirrhosis]. Vnitr Lek (1995) 0.75
[Neuroendocrine changes in chronic heart failure]. Vnitr Lek (1993) 0.75
[Infection of the diabetic foot--appropriate antibiotics and therapeutic strategies]. Vnitr Lek (1998) 0.75
Brain glycogen: an insulin-sensitive carbohydrate store. Diabetes Nutr Metab (2002) 0.75
[Changes in lipoprotein metabolism in patients with diabetes mellitus and the effect on lipid profile in diabetics]. Vnitr Lek (1994) 0.75